Eye on FDA
A series focused on important FDA and related regulatory developments critical to the life sciences industry.
Filter by Category
Search Results
Eye on FDA
On June 24, 2025, in a hearing before the U.S. House of Representatives Committee on Energy and Commerce, the Secretary of Health and Human Services
(HHS), Robert F. Kennedy Jr. revealed that his department plans to soon launch an advertising campaign encouraging Americans to use wearable health
devices. The campaign is set to be “one of the biggest advertising campaigns in HHS history.”
(HHS), Robert F. Kennedy Jr. revealed that his department plans to soon launch an advertising campaign encouraging Americans to use wearable health
devices. The campaign is set to be “one of the biggest advertising campaigns in HHS history.”
Eye on FDA
In this edition of Three Questions, health care & life sciences partner Nate Brown spoke with Jeremy Schutz, director of business development, recall &
remediation at Sedgwick, to explore key strategies that pharmaceutical companies and medical device manufacturers can adopt to mitigate risks related to
supply chain disruptions, cybersecurity threats and increased FDA enforcement of quality control and compliance.
remediation at Sedgwick, to explore key strategies that pharmaceutical companies and medical device manufacturers can adopt to mitigate risks related to
supply chain disruptions, cybersecurity threats and increased FDA enforcement of quality control and compliance.